"use strict";
const {
  Document, Packer, Paragraph, TextRun, AlignmentType,
  HeadingLevel, LevelFormat, PageNumber, NumberFormat,
  Header, Footer, TabStopType, TabStopPosition
} = require("docx");
const fs = require("fs");

// ── helpers ──────────────────────────────────────────────────────────────────
const FONT = "Times New Roman";
const BODY  = 24; // 12 pt
const LINE_SPACING = { line: 480, lineRule: "auto" }; // double spacing

function body(text, opts = {}) {
  return new Paragraph({
    children: [new TextRun({ text, font: FONT, size: BODY, ...opts })],
    spacing: LINE_SPACING,
    alignment: AlignmentType.JUSTIFIED,
  });
}

function bodyRuns(runs) {
  return new Paragraph({
    children: runs.map(r =>
      new TextRun({ font: FONT, size: BODY, ...r })
    ),
    spacing: LINE_SPACING,
    alignment: AlignmentType.JUSTIFIED,
  });
}

function h1(text) {
  return new Paragraph({
    heading: HeadingLevel.HEADING_1,
    children: [new TextRun({ text, font: FONT, size: 28, bold: true })],
    spacing: { before: 360, after: 120, line: 360, lineRule: "auto" },
  });
}

function h2(text) {
  return new Paragraph({
    heading: HeadingLevel.HEADING_2,
    children: [new TextRun({ text, font: FONT, size: 24, bold: true })],
    spacing: { before: 240, after: 80, line: 360, lineRule: "auto" },
  });
}

function blank() {
  return new Paragraph({ children: [new TextRun({ text: "" })], spacing: { line: 240 } });
}

function ref(text) {
  return new Paragraph({
    children: [new TextRun({ text, font: FONT, size: BODY })],
    spacing: { line: 360, lineRule: "auto", before: 60 },
    indent: { left: 720, hanging: 720 },
    alignment: AlignmentType.LEFT,
  });
}

// ── CONTENT ──────────────────────────────────────────────────────────────────
const children = [

  // TITLE PAGE
  new Paragraph({
    children: [new TextRun({ text: "", font: FONT, size: BODY })],
    spacing: { before: 1440 },
  }),
  new Paragraph({
    children: [new TextRun({
      text: "Managing Acute and Chronic Systemic Diseases in Podiatry:",
      font: FONT, size: 28, bold: true,
    })],
    alignment: AlignmentType.CENTER,
    spacing: { line: 480, lineRule: "auto" },
  }),
  new Paragraph({
    children: [new TextRun({
      text: "A Comparative Analysis of Risk and Evidence-Based Care",
      font: FONT, size: 28, bold: true,
    })],
    alignment: AlignmentType.CENTER,
    spacing: { line: 480, lineRule: "auto", after: 480 },
  }),
  new Paragraph({
    children: [new TextRun({ text: "Module: Podiatric Clinical Practice", font: FONT, size: BODY })],
    alignment: AlignmentType.CENTER,
    spacing: { line: 480, lineRule: "auto" },
  }),
  new Paragraph({
    children: [new TextRun({ text: "Word Count: approximately 2,400 words", font: FONT, size: BODY })],
    alignment: AlignmentType.CENTER,
    spacing: { line: 480, lineRule: "auto", after: 2880 },
  }),

  // ── INTRODUCTION ────────────────────────────────────────────────────────
  h1("1. Introduction"),

  body(
    "Disease classification in clinical medicine distinguishes between acute and chronic conditions on the basis of onset, duration, and trajectory. An acute disease is characterised by rapid onset, a relatively short clinical course, and the need for prompt intervention; examples include gout flares, cellulitis, and diabetic foot infection. A chronic disease, by contrast, develops insidiously over months or years, persists for the long term, and causes progressive tissue damage; type 2 diabetes mellitus (T2DM), peripheral arterial disease (PAD), and hypertension are paradigmatic examples (Harrison's Principles of Internal Medicine, 22nd edn, 2025). In podiatric practice, the foot is frequently the end-organ at which the cumulative harm of chronic systemic disease becomes clinically manifest, rendering the podiatrist a critical member of the multidisciplinary team (MDT)."
  ),
  blank(),
  body(
    "This essay uses the clinical presentation of Mr Patel — a 67-year-old male of South Asian ethnicity with T2DM, PAD, hypertension, a previous myocardial infarction (MI), obesity (BMI 32 kg/m²), and a history of gout — to explore the distinction between acute and chronic disease, to analyse the complex risk-factor profile that places him at high risk of limb-threatening complications, and to justify a comprehensive, evidence-based podiatric management plan. The National Institute for Health and Care Excellence (NICE) guideline NG19 (Diabetic Foot Problems: Prevention and Management) and the International Working Group on the Diabetic Foot (IWGDF) 2023 guidelines provide the primary evidence base."
  ),
  blank(),

  // ── LO1 ─────────────────────────────────────────────────────────────────
  h1("2. Learning Outcome 1 — Comparison of Acute and Chronic Diseases"),
  h2("2.1 Chronic Diseases in Mr Patel"),

  body(
    "T2DM is the cornerstone of Mr Patel's chronic disease burden. Persistent hyperglycaemia activates several injurious pathways — including the polyol pathway, advanced glycation end-product accumulation, and protein kinase C activation — that collectively damage the microvasculature and peripheral nervous system (Harrison's Principles of Internal Medicine, 22nd edn, 2025). The microvascular sequelae are diabetes-specific and include peripheral sensorimotor polyneuropathy, which results in loss of protective sensation (LOPS), and autonomic neuropathy, which impairs sweating and skin integrity. Mr Patel's HbA1c of 78 mmol/mol (approximately 9.3%) places him well above the NICE-recommended target of ≤53 mmol/mol, indicating sustained, poorly controlled hyperglycaemia that will have been driving neuropathic damage for years (NICE NG28, 2022). LOPS is the single most important predisposing factor for foot ulceration because it removes the pain signal that ordinarily prompts protective behaviour (IWGDF Prevention Guideline, 2023)."
  ),
  blank(),
  body(
    "PAD in Mr Patel results from accelerated atherosclerosis of the lower-limb arteries, a macrovascular complication that he shares with his cardiovascular history of hypertension and previous MI. Atherosclerosis reduces perfusion to the foot, evidenced clinically by weak pedal pulses and delayed capillary refill time. The combination of reduced arterial inflow and the hypercoagulable, pro-inflammatory state of poorly controlled diabetes impairs both the delivery of immune cells and the clearance of bacterial load, making infection harder to resolve and healing slower to occur (Current Surgical Therapy, 14th edn, 2023). Studies have shown that the coexistence of neuropathy and PAD (neuroischaemic foot) is the highest-risk phenotype for major lower-extremity amputation; approximately 85% of all amputations are preceded by a diabetic foot ulcer (DFU), and the majority of those DFUs occur on the neuroischaemic foot (Current Surgical Therapy, 14th edn, 2023)."
  ),
  blank(),
  body(
    "Hypertension and a previous MI confirm systemic atherosclerosis and reflect shared pathophysiology with PAD. Hypertension exacerbates endothelial dysfunction and accelerates vessel wall remodelling, worsening perfusion to the distal extremities. Obesity (BMI 32 kg/m²) compounds the situation mechanically by increasing plantar pressure, particularly at the first metatarsophalangeal joint (MTPJ), and metabolically by promoting insulin resistance and systemic inflammation, both of which impede wound healing (Fitzpatrick's Dermatology, 2019). Chronic gout — caused by the deposition of monosodium urate crystals, often precipitated at the first MTPJ — causes recurrent joint inflammation, structural deformity over time, and can be diagnostically confounding when it co-presents with infection."
  ),
  blank(),

  h2("2.2 Acute Conditions in the Current Presentation"),

  body(
    "Mr Patel's acute presentation — redness, warmth, swelling, and a blister at the first MTPJ, with mild pyrexia — is consistent with several acute diagnoses that must be systematically differentiated. The most clinically pressing is an infected diabetic foot. The blister represents a portal of entry for bacteria, and the signs of acute inflammation (rubor, calor, tumor) together with systemic fever meet IWGDF/IDSA criteria for at least a mild (Grade 2) infection; extension of cellulitis beyond 2 cm or evidence of deep tissue involvement would elevate this to moderate (Grade 3), requiring inpatient management (IWGDF Infection Guideline, 2023). Staphylococcus aureus — including methicillin-resistant strains — remains the most common pathogen in diabetic foot infections, though polymicrobial infections involving Gram-negative and anaerobic organisms are frequent in chronic or necrotic wounds (Maity et al., 2024; PMID 39165660)."
  ),
  blank(),
  body(
    "An acute gout flare is a plausible differential given Mr Patel's history of gout and the classical first MTPJ location. Gout presents with sudden-onset, severe joint inflammation driven by neutrophil-mediated urate crystal phagocytosis, and erythema can be striking enough to mimic infection. However, fever is less typical in a pure gout flare, and the presence of a blister — an external breach of skin — is more consistent with infection or trauma than with crystal arthropathy. Cellulitis is a third differential: a spreading bacterial skin infection that may present with warmth and erythema without a clear primary ulcer. Finally, acute Charcot neuroarthropathy — a rapidly destructive inflammatory arthropathy occurring in the neuropathic foot — must be considered; it typically presents as a warm, swollen, erythematous foot that is relatively painless due to LOPS, and the absence of pain despite the degree of inflammation is the key distinguishing feature (NICE NG19, 2015, updated 2023)."
  ),
  blank(),

  h2("2.3 The Relationship Between Chronic and Acute Disease"),

  body(
    "A critical conceptual point for podiatric practice is that chronic diseases do not merely co-exist with acute conditions — they actively create the biological and biomechanical milieu in which acute events occur. In Mr Patel's case, T2DM has caused LOPS (which allowed the blister to develop unnoticed), PAD has impaired perfusion (which will obstruct healing and antibiotic delivery), and chronic hyperglycaemia has suppressed innate immunity (which reduces capacity to combat infection). The acute infection is therefore not an independent event but an expected consequence of inadequately managed chronic disease. This understanding is foundational to podiatric risk stratification: chronic disease management is preventive podiatric care."
  ),
  blank(),

  // ── LO2 ─────────────────────────────────────────────────────────────────
  h1("3. Learning Outcome 2 — Risk Factors and Clinical Decision-Making"),
  h2("3.1 Systemic Risk Factors"),

  body(
    "Mr Patel's systemic risk-factor profile is exceptionally complex and warrants detailed analysis. Poorly controlled T2DM (HbA1c 78 mmol/mol) is the dominant driver of both neuropathy and impaired immune function. The IWGDF risk stratification system places individuals with LOPS and PAD in Category 2 (moderate risk), and those with a prior ulcer or amputation in Category 3 (high risk); given the current presentation with active infection, Mr Patel must be managed as high risk (IWGDF Prevention Guideline, 2023). PAD constitutes an independent risk factor that dramatically worsens outcomes: the Trans-Atlantic Inter-Society Consensus (TASC) working group estimates that major amputations resulting from PAD occur in up to 30% of patients with critical limb ischaemia (Current Surgical Therapy, 14th edn, 2023)."
  ),
  blank(),
  body(
    "Age 67 is relevant because peripheral vascular compliance diminishes with age and tissue regeneration is slower. South Asian ethnicity confers a higher prevalence of T2DM, a tendency toward earlier-onset microvascular complications, and higher cardiovascular mortality compared with white European populations, a disparity partly attributable to differences in adiposity distribution and insulin resistance (Harrison's Principles of Internal Medicine, 22nd edn, 2025). Obesity exacerbates plantar pressure and promotes a pro-inflammatory adipokine milieu. Mr Patel's previous MI and hypertension signal a systemic vascular burden that reduces collateral perfusion capacity. Social isolation — living alone with limited mobility — reduces the likelihood of early detection of foot problems and timely help-seeking, which are known independent predictors of delayed presentation and worse outcomes."
  ),
  blank(),

  h2("3.2 Local Risk Factors"),

  body(
    "At the level of the foot, several local factors compound systemic risk. The blister at the first MTPJ — a site subject to peak plantar pressure during the propulsive phase of gait — was almost certainly caused or exacerbated by Mr Patel's habit of walking barefoot and wearing thin-soled slippers. These behaviours expose the neuropathic foot to repetitive mechanical stress without the cushioning and load-distribution that therapeutic footwear provides. The poor vascular supply, demonstrated by weak pedal pulses and delayed capillary refill, means that even minor wound contamination carries a high risk of progression to deep infection or gangrene. Non-weightbearing due to pain has immobilised Mr Patel, which may further impair venous and lymphatic return."
  ),
  blank(),

  h2("3.3 Impact on Clinical Decision-Making"),

  body(
    "The cumulative risk profile described above demands a structured, urgent clinical response. Using validated tools — IWGDF/SINBAD or University of Texas classification for wound staging, ankle-brachial pressure index (ABPI) or toe pressures for vascular assessment, and a 10-g monofilament test for neuropathy — allows objective risk grading. NICE NG19 mandates that any person with an active diabetic foot problem (ulceration, infection, ischaemia, or suspected Charcot) must be referred to the multidisciplinary foot care team within 24 hours of presentation, and that those with limb- or life-threatening problems should be referred immediately to acute services (NICE NG19, 2015, updated 2023). Mr Patel's combination of infection with likely ischaemia triggers that highest-urgency pathway. The clinical decision to refer is not merely procedural — it is evidence-based: MDT-coordinated care has been consistently shown to reduce ulcer recurrence, hospitalisation, and major amputation rates (Maity et al., 2024; PMID 39165660)."
  ),
  blank(),

  // ── LO3 ─────────────────────────────────────────────────────────────────
  h1("4. Learning Outcome 3 — Evidence-Based Management Plan"),
  h2("4.1 Immediate Management"),

  body(
    "The immediate priority is urgent referral to the multidisciplinary diabetic foot team in accordance with NICE NG19 (2015, updated 2023). Pending this, empirical antibiotic therapy should be initiated as per local antimicrobial policy, typically covering Gram-positive cocci in mild-to-moderate infection, with broader Gram-negative and anaerobic coverage added for severe or chronic wounds. The IWGDF/IDSA 2023 infection guideline recommends oral antibiotics for mild infection (Grade 2) and intravenous antibiotics initially for moderate-to-severe infection (Grade 3–4), with de-escalation guided by wound culture results. Duration of treatment for soft-tissue infection is one to two weeks for mild and two to four weeks for moderate infection (IWGDF Infection Guideline, 2023)."
  ),
  blank(),
  body(
    "Wound management should include careful debridement of non-viable tissue and the blister roof, which acts as a reservoir for bacterial colonisation. Debridement in the neuropathic foot can be performed without local anaesthetic; however, caution is required in ischaemic or neuroischaemic feet where tissue viability is marginal and aggressive debridement can extend rather than limit tissue loss (Andrews' Diseases of the Skin, 2018). Wound dressings should maintain a moist wound environment, manage exudate, and minimise the risk of secondary infection; DACC (dialkylcarbamoyl chloride)-coated dressings have emerging evidence supporting their role in managing colonised and infected wounds (Schwarzer et al., 2024; PMID 39362798). Urgent vascular assessment — ABPI or, preferably, toe pressures given the calcification risk in diabetic vessels — should be arranged; if critical limb-threatening ischaemia is identified, vascular surgery review for possible revascularisation is mandatory before definitive wound management can proceed."
  ),
  blank(),
  body(
    "Pressure offloading is the cornerstone of neuropathic ulcer healing, with the total contact cast (TCC) considered the gold-standard device (IWGDF Offloading Guideline, 2023). However, a TCC is contraindicated in the presence of active infection or significant ischaemia due to the risks of occult pressure necrosis and hindering wound monitoring. A removable cast walker (RCW) or prefabricated boot is the appropriate interim device in Mr Patel's case, allowing wound access whilst redistributing plantar load. The patient should be made strictly non-weightbearing if infection is severe."
  ),
  blank(),

  h2("4.2 Long-Term Management"),

  body(
    "Glycaemic optimisation is fundamental to long-term wound healing and infection control. Mr Patel's HbA1c of 78 mmol/mol must be reduced, ideally below 53 mmol/mol, through collaborative management with the GP and diabetologist involving pharmacological adjustment (consideration of GLP-1 receptor agonists or SGLT-2 inhibitors given their additional cardiovascular benefits) and structured diabetes education (Harrison's Principles of Internal Medicine, 22nd edn, 2025). PAD management requires antiplatelet therapy (aspirin or clopidogrel), high-intensity statin therapy to stabilise atherosclerotic plaques, and lifestyle modification. Revascularisation — by endovascular or open surgical means — should be considered when ABPI falls below 0.5 or toe pressures are below 30 mmHg, as these thresholds predict poor wound healing without improved perfusion (IWGDF PAD Guideline, 2023)."
  ),
  blank(),
  body(
    "Regular podiatric follow-up should be structured according to risk category. For Mr Patel, as a high-risk patient, NICE NG19 recommends review every one to three months, encompassing nail care, callus debridement, neurovascular assessment, and footwear review. Custom-made or extra-depth therapeutic footwear with moulded insoles is essential to redistribute plantar pressure and prevent recurrence; footwear prescription should be undertaken in collaboration with an orthotist. Gout management should be reviewed with the GP: long-term urate-lowering therapy (allopurinol, first-line) reduces crystal burden and the frequency of flares, but must be managed carefully in the context of existing renal and cardiovascular comorbidity."
  ),
  blank(),

  h2("4.3 Multidisciplinary Team Coordination"),

  body(
    "The complexity of Mr Patel's case requires seamless MDT coordination. The core team comprises the podiatrist (wound management, offloading, footwear), diabetologist or diabetes specialist nurse (glycaemic optimisation), vascular surgeon (perfusion assessment and revascularisation), tissue viability nurse (wound dressing selection and monitoring), and GP (systemic disease management and medication review). An orthotist contributes to footwear and orthotic provision, and a dietitian may be involved to support weight management and dietary glycaemic control. NICE NG19 emphasises that a named consultant must be accountable for overall care, ensuring that the multiple professional inputs are coordinated rather than fragmented (NICE NG19, 2015, updated 2023). Evidence consistently demonstrates that MDT care models reduce major amputation rates by 49–85% compared with non-coordinated care (Maity et al., 2024; PMID 39165660)."
  ),
  blank(),

  h2("4.4 Patient Education"),

  body(
    "Sustainable self-management is only possible if Mr Patel understands his condition and is equipped with practical skills. Education should be structured, culturally sensitive (acknowledging his South Asian background and any language or health-literacy considerations), and delivered in partnership rather than as passive instruction. Core content includes: daily foot inspection (using a mirror or smartphone camera if visual acuity is limited), strict avoidance of barefoot walking, correct footwear selection, nail and skin care, recognising warning signs (new redness, swelling, warmth, or broken skin) that demand same-day podiatric or medical review, and the importance of glycaemic and cardiovascular risk-factor management. In Mr Patel's case, the preventable nature of the precipitating blister — caused by thin footwear — should be explored non-judgementally, with emphasis on empowerment rather than blame. Social support services should be engaged given that he lives alone, as social isolation is independently associated with delayed help-seeking and worse outcomes in diabetic foot disease."
  ),
  blank(),

  h2("4.5 Evidence Integration"),

  body(
    "The management plan described is grounded in four key evidence sources. NICE NG19 (2015, last reviewed 2023) provides the UK standard of care, mandating 24-hour MDT referral for active foot problems and structured risk-stratified review. The IWGDF 2023 guidelines — covering prevention, infection, offloading, wound healing, and PAD — represent the international consensus, produced through systematic review of the global literature. The Royal College of Podiatry (RCoP) clinical guidelines align closely with NICE and IWGDF, providing UK-specific practice guidance. A recent systematic review by Maity et al. (2024; PMID 39165660) synthesised evidence on pathogenesis, diagnosis, and management strategies in diabetic foot infection, reinforcing the importance of early MDT intervention and culture-guided antibiotic therapy. A further systematic review on foot ulcer classification (Monteiro-Soares et al., 2024; PMID 37132179) supports the use of validated risk-stratification tools to guide clinical decision-making. Together, these sources underpin every element of the management plan proposed for Mr Patel."
  ),
  blank(),

  // ── CONCLUSION ──────────────────────────────────────────────────────────
  h1("5. Conclusion"),

  body(
    "Mr Patel's presentation illustrates the clinical reality that acute and chronic diseases are not independent events but deeply interconnected processes. His long-standing chronic diseases — T2DM, PAD, hypertension, and obesity — have collectively created a foot that is neuropathic, ischaemic, and immunocompromised. Within this environment, a seemingly minor acute event — a blister caused by inadequate footwear — has the potential to escalate rapidly into deep infection, osteomyelitis, or limb-threatening ischaemia. The podiatrist's role is therefore both reactive (managing the acute crisis) and prospective (anticipating and mitigating the chronic disease trajectory that makes crises inevitable)."
  ),
  blank(),
  body(
    "Early recognition of high-risk features, urgent MDT referral in line with NICE NG19, evidence-based wound and infection management per IWGDF guidelines, and sustained systemic risk-factor optimisation together constitute the standard of care. Patient education and social support are equally essential components: the objective is to build Mr Patel's capacity for effective self-management so that future complications can be detected early and, ideally, prevented. Podiatric care must be anticipatory rather than purely reactive — the evidence is unequivocal that proactive, multidisciplinary, risk-stratified care saves limbs and lives."
  ),
  blank(),

  // ── REFERENCES ──────────────────────────────────────────────────────────
  h1("References"),

  ref("Andrews, M.D. and Burns, M. (2018) Andrews' Diseases of the Skin: Clinical Dermatology. 13th edn. Philadelphia: Elsevier."),
  ref("Fitzpatrick, T.B. et al. (2019) Fitzpatrick's Dermatology. 9th edn. New York: McGraw-Hill."),
  ref("Fauci, A.S. et al. (2025) Harrison's Principles of Internal Medicine. 22nd edn. New York: McGraw-Hill."),
  ref("Fischer, J.E. et al. (2023) Current Surgical Therapy. 14th edn. Philadelphia: Elsevier."),
  ref("International Working Group on the Diabetic Foot (IWGDF) (2023) IWGDF Guidelines on the Prevention and Management of Diabetes-Related Foot Disease. Available at: https://iwgdfguidelines.org (Accessed: 7 May 2026)."),
  ref("Lipsky, B.A. et al. (2023) Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF/IDSA 2023). Diabetes/Metabolism Research and Reviews. [Online]. Available at: https://iwgdfguidelines.org (Accessed: 7 May 2026)."),
  ref("Maity, S., Leton, N. and Nayak, N. (2024) 'A systematic review of diabetic foot infections: pathogenesis, diagnosis, and management strategies', Frontiers in Clinical Diabetes and Healthcare. [Systematic Review] PMID: 39165660."),
  ref("Monteiro-Soares, M. et al. (2024) 'Classification of foot ulcers in people with diabetes: a systematic review', Diabetes/Metabolism Research and Reviews, 40(2). [Systematic Review] PMID: 37132179."),
  ref("National Institute for Health and Care Excellence (NICE) (2015, updated 2023) Diabetic Foot Problems: Prevention and Management (NG19). London: NICE. Available at: https://www.nice.org.uk/guidance/ng19 (Accessed: 7 May 2026)."),
  ref("National Institute for Health and Care Excellence (NICE) (2022) Type 2 Diabetes in Adults: Management (NG28). London: NICE. Available at: https://www.nice.org.uk/guidance/ng28 (Accessed: 7 May 2026)."),
  ref("Rosen, P. et al. (2022) Rosen's Emergency Medicine: Concepts and Clinical Practice. 9th edn. Philadelphia: Elsevier."),
  ref("Royal College of Podiatry (RCoP) (2021) Podiatric Management of the Diabetic Foot. London: RCoP. Available at: https://www.rcpod.org.uk (Accessed: 7 May 2026)."),
  ref("Schwarzer, S. et al. (2024) 'Does the use of DACC-coated dressings improve clinical outcomes for hard-to-heal wounds? A systematic review', International Wound Journal, 21(10). [Systematic Review] PMID: 39362798."),
  ref("Scottish Intercollegiate Guidelines Network (SIGN) (2017) Management of Diabetes: A National Clinical Guideline (SIGN 116, updated). Edinburgh: SIGN."),
  ref("Bus, S.A. et al. (2023) Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. Available at: https://iwgdfguidelines.org (Accessed: 7 May 2026)."),
  ref("Fitridge, R. et al. (2023) The intersocietal IWGDF/ESVS/SVS guidelines on peripheral artery disease in patients with diabetes mellitus and a foot ulcer. Diabetes/Metabolism Research and Reviews. Available at: https://iwgdfguidelines.org (Accessed: 7 May 2026)."),
  ref("Nsekpong, T.B., Amin, A.S. and Ali, S.R. (2025) 'Comparative analysis of secondary outcomes in treatment of Charcot neuropathy: a systematic review', Foot & Ankle Specialist, 18(2). [Systematic Review] PMID: 35778875."),
];

// ── BUILD DOCUMENT ────────────────────────────────────────────────────────────
const doc = new Document({
  styles: {
    default: {
      document: { run: { font: FONT, size: BODY } },
    },
    paragraphStyles: [
      {
        id: "Heading1",
        name: "Heading 1",
        basedOn: "Normal",
        next: "Normal",
        quickFormat: true,
        run: { size: 28, bold: true, font: FONT, color: "000000" },
        paragraph: { spacing: { before: 360, after: 120 }, outlineLevel: 0 },
      },
      {
        id: "Heading2",
        name: "Heading 2",
        basedOn: "Normal",
        next: "Normal",
        quickFormat: true,
        run: { size: 24, bold: true, font: FONT, color: "000000" },
        paragraph: { spacing: { before: 240, after: 80 }, outlineLevel: 1 },
      },
    ],
  },
  sections: [
    {
      properties: {
        page: {
          size: { width: 11906, height: 16838 }, // A4
          margin: { top: 1440, right: 1440, bottom: 1440, left: 1440 },
        },
      },
      footers: {
        default: new Footer({
          children: [
            new Paragraph({
              alignment: AlignmentType.RIGHT,
              children: [
                new TextRun({ children: [PageNumber.CURRENT], font: FONT, size: BODY }),
              ],
            }),
          ],
        }),
      },
      children,
    },
  ],
});

Packer.toBuffer(doc).then(buf => {
  fs.writeFileSync("/home/daytona/workspace/mr-patel-essay/MrPatel_Assignment.docx", buf);
  console.log("Done.");
});